Johannes Pöhlmann

15PUBLICATIONS
37CO-AUTHORS
Regenerative medicine (incl. stem cells)Artificial life and complex adaptive systemsMedical roboticsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 05, 2025
Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UK.

Matthew Tucker, Johannes Pöhlmann, Kristin Grabe-Heyne

|Oct 08, 2025
A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes.

Johannes Pöhlmann, Jayne Smith-Palmer, Erik H Serné

|Sep 19, 2025
Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin Delivery.

Sufyan Hussain, Asli Zeynep Ozdemir Saltik, Jessica J Yu

|Apr 08, 2025
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.

Manuel De la Torre-Aláez, Ana Matilla, María Varela

|Mar 22, 2025
Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost-Consequence Analysis for High-Risk Patients in Primary Care in Germany.

Johannes Pöhlmann, Anika Joecker, Tanja Wittki

|Mar 18, 2025
Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c <8%: A Cost-Utility Analysis in The Netherlands.

Erik H Serné, Maria Ida Buompensiere, Simona de Portu

Pageof 3

Frequent Collaborators

9 joint publications

Richard F Pollock

3 joint publications

Ohad Cohen

3 joint publications

Jayne Smith-Palmer

2 joint publications

Shanlian Hu